Search Results - "FELDMAN, R. S"

Ultraviolet phototherapy for cutaneous diseases: a concise review by Vangipuram, R, Feldman, SR

“…Phototherapy is the use of non‐ionizing radiation, primarily in the ultraviolet spectrum, to treat disease. In dermatology, ultraviolet (UV) phototherapy…”
Get full text

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials by Papp, K.A., Menter, M.A., Abe, M., Elewski, B., Feldman, S.R., Gottlieb, A.B., Langley, R., Luger, T., Thaci, D., Buonanno, M., Gupta, P., Proulx, J., Lan, S., Wolk, R.

“…Summary Background Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. Objectives To determine the 16‐week efficacy and safety of…”
Get full text

The genetics of pyoderma gangrenosum and implications for treatment: a systematic review by DeFilippis, E.M., Feldman, S.R., Huang, W.W.

“…Summary Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful skin ulcerations for which treatment can be challenging. The…”
Get full text

Evidence is lacking for or against palmoplantar pustulosis treatments: what does this mean for the clinician by Feldman, S.R., Huang, W.W.

“…Linked Article: Obeid et al. Br J Dermatol 2021; 184:1023–1032…”
Get full text

Biologics are too complicated to duplicate: should we be worried about biosimilars? by Cline, A, Feldman, S.R.

“…Linked Article: Blauvelt et al. Br J Dermatol 2018; 179:623–631…”
Get full text

A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial by Svendsen, M.T., Andersen, F., Andersen, K.H., Pottegård, A., Johannessen, H., Möller, S., August, B., Feldman, S.R., Andersen, K.E.

“…Summary Background Adherence to topical psoriasis treatments is low, which leads to unsatisfactory treatment results. Smartphone applications (apps) for…”
Get full text

A changed life: the life experiences of patients with psoriasis receiving biological treatment by Trettin, B., Feldman, S.R., Andersen, F., Danbjørg, D.B., Agerskov, H.

“…Summary Background Psoriasis has a large negative impact on quality of life and is associated with both depression and anxiety. The introduction of biologics…”
Get full text

A hands‐off approach may be more successful in treating chronic hand eczema by Strowd, L.C., Feldman, S.R.

“…Linked Article: Worm et al. Br J Dermatol 2020; 182:1103–1110…”
Get full text

The perceived promise of p19 inhibitors by Cline, A., Feldman, S.R.

“…Linked Article: Blauvelt et al. Br J Dermatol 2018; 179:615–622…”
Get full text

Tildrakizumab: interpreting the data by Purvis, C.G., Emmerich, V.K., Feldman, S.R.

“…Linked Article: Thaçi et al. Br J Dermatol 2021; 185:323–334…”
Get full text

Overcoming poor adherence is a major hurdle to managing atopic dermatitis by Strowd, L.C., Feldman, S.R.

“…Linked Article: Choi et al. Br J Dermatol 2020; 182:1017–1025…”
Get full text

Long‐term adherence to topical psoriasis treatment can be abysmal: a 1‐year randomized intervention study using objective electronic adherence monitoring by Alinia, H., Moradi Tuchayi, S., Smith, J.A., Richardson, I.M., Bahrami, N., Jaros, S.C., Sandoval, L.F., Farhangian, M.E., Anderson, K.L., Huang, K.E., Feldman, S.R.

“…Summary Background Most people with psoriasis have limited disease that could be treated with topicals, but topical efficacy is limited by low short‐term…”
Get full text

Lead with your gut: research‐implicated infant gut staphylococcal strains may predict development of atopic dermatitis by Strowd, L.C., Feldman, S.R.

“…Linked Article: Nowrouzian et al. Br J Dermatol 2019; 180:1481–1488…”
Get full text

Dermatology Life Quality Index: does improving the instrument make it better? by Bashyam, A.M., Feldman, S.R.

“…Linked Article: Rencz et al. Br J Dermatol 2020; 182:1167–1175…”
Get full text

Participating in trials can inform better clinical practice by Feldman, S.R.

“…Linked Article: Batchelor et al. Br J Dermatol 2017; 177:e228–e234…”
Get full text

Yet another step forward by Feldman, S.R.

“…Linked Article: Gordon et al. Br J Dermatol 2018; 178:132–139…”
Get full text

Long‐term efficacy of certolizumab pegol for psoriasis by Johnson, M.C., Heron, C.E., Feldman, S.R.

“…Linked Article: Gordon et al. Br J Dermatol 2021; 184:652–662…”
Get full text

Comparison of injection‐site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study by Girolomoni, G., Feldman, S.R., Emery, P., Ghil, J., Keum, J.W., Cheong, S.Y., Hong, E.

Get full text

Engagement can increase patient willingness to take medications by Johnson, M.C., Oussedik, E., Joshi, K., Feldman, S.R.

Get full text

Economic evaluation of systemic therapies for moderate to severe psoriasis by Sizto, S., Bansback, N., Feldman, S.R., Willian, M.K., Anis, A.H.

“…Summary Background  New biologics have dramatically changed therapeutic options for psoriasis, albeit at additional cost. Objectives  To determine the…”
Get full text